Related Experiment Video
Updated: Aug 13, 2026
An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
Published on: January 25, 2019
Evaluation of drug treatments for proliferative vitreoretinopathy using vitreous microtensiometry
L C Moorhead1, S Sepahban, C D Armeniades
1Department of Chemical Engineering, Rice University, Houston, Texas.
Abstract:
The effectiveness of antimetabolic and anticollagen agents against proliferative vitreoretinopathy (PVR) was assessed by vitreous microtensiometry, a new technique that measures in situ the tensile strength of vitreous membranes. Two PVR models were produced in rabbits by intravitreal injection of bovine retinal pigment epithelial (RPE) or fibroblast cells, and the animals subsequently were treated with 5-fluorouracil (5-FU) and beta-aminopropionitrile (BAPN), administered alone or in combination. The fibroblast PVR model produced high-strength membranes that did not respond significantly to these therapies. The RPE model gave lower-strength membranes that showed marginally significant decreases in strength with intravitreal 5-FU and systemic BAPN treatments. However, combination therapy showed a highly significant decrease in membrane strength and a clinically encouraging reduction in retinal detachment.
Insights
New research on proliferative vitreoretinopathy (PVR) shows combination therapy with 5-fluorouracil (5-FU) and beta-aminopropionitrile (BAPN) significantly reduced membrane strength and retinal detachment in a rabbit model.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Pharmacology
Background:
- Proliferative vitreoretinopathy (PVR) is a severe complication of retinal detachment, characterized by the formation of contractile membranes.
- Current treatments for PVR have limited efficacy, necessitating the development of novel therapeutic strategies.
Purpose of the Study:
- To evaluate the efficacy of antimetabolic (5-fluorouracil) and anticollagen (beta-aminopropionitrile) agents in reducing the strength of PVR membranes.
- To assess the utility of vitreous microtensiometry as a novel technique for measuring in situ tensile strength of vitreous membranes.
Main Methods:
- Two rabbit models of PVR were established using intravitreal injection of bovine retinal pigment epithelial (RPE) or fibroblast cells.
- Animals were treated with 5-fluorouracil (5-FU) and beta-aminopropionitrile (BAPN) alone or in combination, administered via intravitreal or systemic routes.
- Vitreous microtensiometry was employed to measure the tensile strength of the formed PVR membranes.
Main Results:
- Fibroblast-induced PVR membranes were high-strength and unresponsive to the tested therapies.
- RPE-induced PVR membranes showed a marginally significant decrease in strength with intravitreal 5-FU and systemic BAPN treatment.
- Combination therapy (5-FU and BAPN) resulted in a highly significant reduction in RPE-induced PVR membrane strength and a clinically encouraging decrease in retinal detachment.
Conclusions:
- Combination therapy with 5-FU and BAPN demonstrates significant potential in reducing PVR membrane strength and mitigating retinal detachment.
- Vitreous microtensiometry is a valuable tool for assessing the biomechanical properties of PVR membranes and evaluating therapeutic interventions.
